■ Healthcare
Continued From Page 34 designed to kill cancer cells and spare healthy cells . To date , mirvetuximab has generated promising data in patients with platinum-resistant ovarian cancer ; this study in platinum-sensitive ovarian cancer is designed to address another patient population with high unmet need .
The PICCOLO study is among a significant and growing portfolio of groundbreaking clinical trials offered through Holy Name ' s Institute for Clinical Research . Right now , there are more than a dozen investigational studies — and several more in the pipeline — that specifically involve treatments for gynecologic cancers . All studies are carefully controlled and closely monitored to ensure the safety of participants .
“ Holy Name is proud to provide access to this important clinical trial to our patient population and women around the tri-state area . Participating in national trials puts Holy Name in a league with some of the most respected research and medical centers in the country ,” says Dr . Lewin . “ Through our continued participation in clinical trials like PICCOLO , we ’ re contributing to studies designed to improve outcomes , including quality of life and progression-free survival for the women who trust us with their care .”
( L-R ) Keith Banks , co-chair , Hackensack Meridian Health Foundation Board of Trustees ; Kenneth N . Sable , M . D ., MBA , FACEP , regional president , Southern Market , Hackensack Meridian Health ; Joyce P . Hendricks , president and chief development officer , Hackensack Meridian Health Foundation ; Peter Cancro , founder and CEO , Jersey Mike ’ s ; Tatiana Cancro ; Robert C . Garrett , FACHE , CEO , Hackensack Meridian Health ; Vito Buccellato , MPA , LNHA , chief hospital executive , Jersey Shore University Medical Center ; Walter ( Rob ) Earle , vice chairman , Jersey Shore University Medical Center Foundation ; and Paul Huegel , vice president of Development , Jersey Shore University Medical Center Foundation .
The Cancros Pledge $ 10M to Hackensack Meridian Health
Hackensack Meridian Health Foundation has announced an extraordinary gift of $ 10 million from Jersey Mike ’ s Founder Peter Cancro and his wife Tatiana to benefit Hackensack Meridian Health .
“ This tremendous commitment of $ 10 million from Peter and Tatiana will benefit the communities we proudly serve in extraordinary ways and we are so grateful for their
generosity ,’’ says Robert C . Garrett , FACHE , CEO , Hackensack Meridian Health . “ Peter and Tatiana have been dedicated to Hackensack Meridian Health and our medical centers for more than 25 years . This exceptional gift will support our bold mission to transform healthcare in New Jersey and beyond .’’
Cancro , the founder and chief executive officer of Jersey Mike ’ s Franchise Systems , is a graduate of Point Pleasant Beach High School . He began his business career in 1971 when he was employed at Mike ’ s Subs . Shortly thereafter , at age 17 , he decided to forego a potential college football career and purchased Mike ’ s Subs . In 1987 , Cancro changed the name of the original Mike ’ s to “ Jersey Mike ’ s ” and began his national expansion .
“ Philanthropy has been a part of my life and a guiding principle of Jersey Mike ’ s success ,” he explains “ Tatiana and I are pleased to be able to support Hackensack Meridian Health .”
Cancro is chairman emeritus of Hackensack Meridian Jersey Shore University Medical Center Foundation ’ s Board of Trustees , serving on the board from 1994 to 2003 and then 2005 to 2016 , five of those years ( 2012-2016 ) as Chairman .
The Valley Hospital in Paramus , to open in late 2023 ( rendering )
$ 125M Fundraising Campaign for The Valley Hospital in Paramus
With the opening of The Valley Hospital in Paramus scheduled for the end of 2023 , The Valley Hospital Foundation has announced a $ 125 million fundraising campaign , Serve . Care . Transform . The Next Chapter of The Valley Hospital , in support of the project . The Foundation also announced that Vincent Forlenza , Chairman , Valley Health System Board of Trustees ; Carol Gillespie ; and Michael A . Ietta , M . D ., Bergen Anesthesia Group ; will serve as Campaign Co- Chairs . To date , more than $ 90 million has been raised toward the Serve . Care . Transform . campaign goal , which is scheduled to run through 2024 .
The new 40-acre campus will house an acute-care , 372-bed hospital ; a medical office building ; and the Luckow Pavilion , Valley ’ s
Continued On Page 38
36 COMMERCE www . commercemagnj . com